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December 20101732 Abstractstogenarians were more likely to undergo CAS (as opposed to CEA) than
asymptomatic younger patients (10.1% vs 5.7%, P  .001). In separate
analysis of octogenarians alone, it was noted that they had a significantly
higher rate of periprocedural stroke with CAS than with CEA (2.2% vs 1.1%,
P  .01). The increased rate of stroke with CAS as opposed to CEA was
noted in both asymptomatic (1.9% vs 0.9%, P .04) and symptomatic (5.2%
vs 2.3%, P  .18) octogenarians.
Conclusions: Nationally, octogenarians comprise nearly 20% of pa-
tients undergoing carotid revascularization procedures, despite concern
regarding the benefits of these procedures in older patients, particularly
when asymptomatic. In spite of additional specific concerns regarding the
complication rate of CAS in patients older than 80 years of age, asymptom-
atic octogenarians underwent CAS as opposed to CEA significantly more
frequently than younger patients. However, their periprocedural stroke rate
overall was equally low when compared to younger patients. Furthermore,
among octogenarians, the rate of periprocedural stroke was significantly
higher with CAS than with CEA, and this remained a significant finding
when asymptomatic cases were separately examined. CEA may be the
treatment of choice for properly selected octogenarians, unless compelling
reasons exist to perform CAS.
Renal Artery Stenting for Salvage of Renal Function: Preoperative
Predictors of Outcome Guide Patient Selection
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A. Arko, III, R. James Valentine, G. Patrick Clagett, Clayton Trimmer,
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Background: Improved renal function after renal artery bypass surgery
has been associated with improved dialysis-free survival. Unfortunately,
renal artery bypass in patients with ischemic nephropathy carries a 4% to 7%
operative mortality rate. Renal artery stenting (RAS) offers a lower risk of
mortality, but the clinical response rates for RAS have been disappointing.
We surmise that the poor results for RAS are related to inadequate patient
selection. The purpose of this study was to identify preoperative clinical
features that predict a durable improvement in renal function with RAS.
Methods: The study cohort consisted of 43 patients with renal insuf-
ficiency (serum creatinine  1.5 mg/dL) who underwent RAS for renal
salvage. Patients were categorized as “responders” if estimated glomerular
filtration rate (eGFR) at last follow-up was improved 20% or more over
baseline. Patients with stable or worse renal function after RAS were labeled
“nonresponders.” For the purpose of calculating changes in eGFR, patients
on dialysis were represented by an eGFR of 10 mL/min/1.73 m2. Renal
volume was estimated as kidney length  width  depth/2.
Results: The median age of the cohort was 69 years (interquartile
range, IQR, 61-73 years). Median preoperative serum creatinine was 1.8
mg/dL (IQR 1.6-2.3), and median eGFR was 39 mL/min/1.73 m2 (IQR
21-46). With stenting, 11 of 43 patients (25.6%) derived a durable improve-
ment in renal function at a median follow-up of 26 months (IQR 16-36
months). Responders enjoyed a 54% improvement in renal function from
baseline, while nonresponders had a 7% decrement in renal function (P 
.0001). Responders had a higher diastolic blood pressure, higher baseline
serum creatinine, lower eGFR, and a steeper decline in renal function prior
to RAS (Table). Kidney length, width, depth, and volume were not signif-
icantly different between responders and nonresponders (Table). Logistic
regression analysis identified the rate of decline of renal function prior to
stenting as the only independent predictor of improved renal function after
RAS (odds ratio 16.7, 95% confidence interval 1.9-147.0; P  .011).
Indeed, the rate of decline in eGFR per week was more than 18-fold greater
for responders than nonresponders (3.4% vs 0.18% decline in eGFR per
week; P  .0001).
Conclusions: The current study found that a steep decline in preop-
erative renal function portends a higher likelihood of renal salvage from RAS
among patients with renal insufficiency. Incorporating this finding into
patient selection may improve outcomes for RAS.
Variables Responders Nonresponders P value
Age 71 years 68 years .62
Gender 55% male 66% male .43
Systolic blood
pressure
172 mm Hg 145 mm Hg .15
Diastolic blood
pressure
86 mm Hg 73 mm Hg .015
Serum
creatinine
2.4 mg/dL 1.7 mg/dL .025
eGFR 21 ml/min/1.72m2 42 ml/min/1.72 m2 .027
Percent decline
in preop
eGFR per
week
3.4 % / week 0.18 % / week  .0001
Proportion
with solitary
18% 13% .64kidneysContinued.
Variables Responders Nonresponders P value
Kidney Length 9.6 cm 9.8 cm .72
Kidney Width 5.3 cm 5.4 cm .20
Kidney Depth 5.0 cm 5.1 cm .70
Kidney Volume 123 cm3 129 cm3 .53
Carotid Revascularization Outcomes Comparing Distal Filters, Flow
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Introduction: Contradictory outcomes exist for different methods of
carotid artery revascularization. Here we provide the comparative rates of
adverse events in patients after carotid endarterectomy (CEA), carotid artery
stenting (CAS) with distal protection (EPD), and CAS with flow reversal
technology (FRS) from a single institution by various specialists treating
carotid artery disease.
Methods: Procedural billing codes and the electronic medical records
of patients undergoing carotid artery revascularization for carotid artery
stenosis from February 2007 through March 2010 were utilized for data
collection. Primary outcome was the incidence of stroke, MI, or death after
CEA and CAS. The choice of therapy was determined by the individual
practitioner with some specialists providing both CAS and CEA (5/14).
Baseline characteristics were examined for effect on outcome. Planned
comparisons between and within groups were analyzed using 2, t tests, and
ANOVA as appropriate.
Results: There were 495 total procedures divided into carotid endar-
terectomies (226), CAS with EPD (216), and CAS with FRS (53). Preop-
erative comparisons of patient comorbidities were similar between cohorts.
Forty-two percent of these patients were symptomatic from their carotid
artery stenosis. Prior CEA was an indication for CAS over CEA (P  .001).
Significantly fewer patients undergoing CEAwere on preoperative antiplate-
let therapy (P .001) (Table I). There was no difference between groups in
the overall composite end point of death, stroke, andMI (4%, 5.1%, 0%; P
.1) or any individual major adverse event (Table II). Overall, CAS with EPD
had a statistically significant greater incidence of minor strokes when com-
pared to CEA (P  .031) which was driven by the increased stroke risk for
asymptomatic patients. Secondary endpoints occurred rarely (2%) as listed
in Table 3. There have been no reoperations or interventions in these
patients to date within this institution.
Conclusions: We have established a similar and low incidence of MI,
stroke, and death among patients undergoing CEA and CAS of whom
approximately 40%were symptomatic. The flow reversal system has provided
superior results in this series; however, its use was limited to 20% of the
carotid artery stenting procedures. Still zero adverse events in this cohort
make this an exciting technology that warrants a large-scale prospective
comparative study.
Table I. Patient characteristics
CEA
CAS 
EPD
CAS 
FRS P values
Overall
n 
226
n 
216
n 
53 Overall
CEA/
EPD
CEA/
FRS
Gender 
Female
41% 38% 42% .80 .55 .91
Age .62 .65 .49
Median
(years)
70 70 69
80 years 14% 21% 19%
Symptomatic 41% 45% 32.7% .27 .43 .26
Prior CEA 12% 29% 27% .001 .001 .017
Hypertension 94% 92% 86% .13 .50 .062
Hyperlipidemia 82% 87% 69% .014 .15 .046
Renal
Disease
9% 11% 2% .084 .46 .067
Prior CVA 29% 22% 17% .087 .090 .065
Prior TIA 31% 40% 46% .067 .058 .062
Diabetes 35% 41% 36% .44 .21 .85
Prior MI 15% 13% 21% .42 .63 .31
Plavix 35% 96% 96% .001 .001 .001therapy
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CEA
CAS 
EPD
CAS 
FRS P values
Overall
n 
226
n 
216
n 
53 Overall
CEA/
EPD
CEA/
FRS
ASA therapy 91% 91% 81% .104 .81 .038
Coumadin
therapy
8% 8% 0% .019 .97 .006
CAS, Carotid artery stenting; CAS  EPD, carotid artery stenting plus distal
embolic filter protection;CAS FRS, carotid artery stenting plus flow reversal
system protection; CEA, carotid endarterectomy; CEA/EPD, comparison of
CEA versus CAS EPD; CEA/FRS, comparison of CEA versus CAS FRS.
Table II. Primary events at 30 days
CEA
CAS 
EPD
CAS 
FRS P value
Overall
n 
226
n 
216
n 
53 Overall
CEA/
EPD
CEA/
FRS
MAE 4.0% (8) 5.1% (9) 0.0% (0) .100 .61 .15
Stroke 2.0% (4) 4.0% (7) 0.0% (0) .131 .26 .18
Minor
Stroke
0.5% (1) 3.4% (6) 0.0% (0) .070 .031 .50
Major
Stroke
1.5% (3) 0.6% (1) 0.0% (0) .400 .36 .24
MI 0.0% (0) 0.0% (0) 0.0% (0) - - -
Death (n 
425)
1.5% (3) 1.7% (3) 0.0% (0) .464 .88 .24
CAS, Carotid artery stenting; CAS  EPD, carotid artery stenting plus distal
embolic filter protection;CAS FRS, carotid artery stenting plus flow reversal
system protection; CEA, carotid endarterectomy; CEA/EPD, comparison of
CEA versus CAS EPD; CEA/FRS, comparison of CEA versus CAS FRS.
Endovascular Aneurysm Repair and the Anatomic Severity Grading
Score: A Validation Study with Early Outcomes and Cost Analysis
Sadaf S. Ahanchi, Babatunde H. Almaroof, Jean M. Panneton, Eastern
Virginia Medical School, Norfolk, Va
Background: Endovascular aneurysm repair (EVAR) is an established
alternative to open surgery for the management of abdominal aortic aneurysms
(AAA). It is commonly understood that the anatomic complexity of an aneu-
rysm impacts the technical difficulty of repair. Yet, little research has been done
to correlate the relationship of aneurysm anatomy to technical difficulty and
early outcomes. Additionally, the anatomic diversity of aneurysms makes out-
come comparisons in the literature difficult to interpret. Adjusting for aneurysm
anatomic variability thus provides one method to obtain some measure of
confidence in comparing outcomes in the literature. The objective of adjusting
for anatomic variability is best achieved with scoring schemes incorporating all
factors affecting the outcomes being assessed. Grading scales to define the
severity of anatomic factors have been reported and validated for lower-extrem-
ity peripheral vascular and venous disease. Accordingly in 2002, a system for the
grading of abdominal aortic aneurysms was developed by the Society for
Vascular Surgery/American Association for Vascular Surgery (SVS/AAVS).
The calculated score assumes that the components of the score influence the
difficulty of EVAR. Unfortunately, the correlation of anatomic severity grading
(ASG) score to patient outcomes within a database has yet to be validated.
Accordingly, we provide our experience with calculating ASG score usingM2S
3D image rendering software and provide the practical translation of this score
into early outcomes.
Methods: All patients who underwent an EVAR for infrarenal AAA
between April 2009 and July 2010 by the Division of Vascular Surgery at
Eastern Virginia Medical School were retrospectively identified using CPT
codes 34800, 34803, 34804, and 34805. To minimize the number of con-
founding variables, we limited our study to patients who had placement of a
Talent™ or Aneurx™ endograft (Medtronic®,Minneapolis, MN) and who had
preoperative M2S imaging (M2S©, West Lebanon, NH). Patients who under-
went EVAR for ruptured aneurysm, aortoiliac occlusive disease, or penetrating
abdominal aortic ulcers were excluded. A retrospective chart review of the
electronicmedical record was completed. Recorded patient demographic infor-
mation included age, sex, past medical history, risk factors, and indication for
operation. Indication for operation was defined as either asymptomatic or
symptomatic. All measurements were based on the planned deployment site asdetermined by preoperative imaging. Operative records and postoperative visits
were also examined and intraoperative procedural data and outcomes were
recorded accordingly to the SVS/AAVS guidelines. Lastly, operative supply
costs andhospital charge informationwas obtained from thebillingdepartment.
The total ASG score for each patient was calculated based on aortic neck,
aneurysm, and iliac anatomic factors, such as diameter, length, angulation,
and tortuosity according to the SVS/AAVS guidelines. The mean total ASG
score for the data set was then used to create two independent patient
groups: a low ASG score group (score 14) and a high ASG score group
(score of 14). Both groups were compared for intraoperative and 30-day
outcomes including the use of adjunctive procedures, operating room
supply cost, and hospital charges. Values are given as mean  standard
deviation unless otherwise noted. Fisher exact test and Student t test were
used to compare nominal and continuous variables respectively for the two
independent groups. P value less than .05 was considered statistically significant.
Results:Of the157patientswhounderwentEVARduring the16-month
study period, a total of 108patientsmet our inclusion criteria. The remaining49
patients were excluded because of their ruptured or nonaneurysmal indication
for repair, lack of preoperative M2S imaging, or use of alternative endograft.
The mean time interval between preoperative imaging and EVAR was 3
months. Themean age was 75 years (range 60-88 years). Amajority of patients
were male (78%), Caucasian (81%), and asymptomatic (91%). Seventy-percent
of patients received the Talent endograft and the remaining 30% received the
Aneurx endograft. Ninety-seven percent of patients received bifurcated en-
dografts, while the remaining 3% received uni-iliac endografts. There were 56
patients in the low ASG group and 52 in the high ASG group. Demographic
data, risk factors, indications, and endografts were comparable between the
two groups. Intraoperative outcomes were significantly different in the low
score group vs high score group: operative time (113 minutes vs 210
minutes, P  .0001), blood loss (227 mL vs 866 mL, P  .0002), and
amount of contrast used (100 mL vs 131 mL, P  .032). The low score
group also used an average of three endograft implants during the case,
whereas the high score group used an average of four (P .001). Access site
adjuncts were 14% in the low score group compared to 50% in the high score
group (P  .0001). Endarterectomy, patch angioplasty, and percutaneous
angioplasty were the most common access site adjuncts. Intraoperative
adjuncts were 54% in the low score group vs 80% in the high score group
(P  .004). Distal limb extension, access site management, and iliac artery
occlusive disease management were the most common adjuncts. Seventy-
five percent of these adjuncts were endovascular. EVAR was technically
successful in all patients, with no conversions to an open repair. No statistical
difference in the incidence of graft limb issues such as kinking, twisting, or
stenosis between the two groups were identified (14% low ASG group vs 4%
high ASG group, P  .06). The average length of hospital stay was 3 days.
The average length of hospital stay for the low score groupwas 2 days and for
the high score group was 5 days (P  .012). Postoperatively, our mean
follow-up length was 5 months. There were no deaths within 30 days of the
procedure and no aneurysm related deaths during follow up. Two individ-
uals (3.7%) died during extended follow-up, both belonging to the high
anatomic score group. Total supply cost and charges related to aneurysm
repair also differed based on ASG score. Mean operating room supply cost
was $16,646 for the low score group vs $25,765 for the high score group
(P .006). Mean total hospital charge was $70,956 for the low score group
vs $105,153 for the high score group (P .016). The difference in technical
difficulty of EVAR in the high vs low ASG score group is evident in the
details of the operation. Operative time was 46% longer, 24% more contrast
was used, and blood loss was 74% more in the high anatomic score group.
These results are despite equivalent devices being used. EVAR for the high
vs low ASG score had more endograft implants used (3 vs 4), 36% more
access adjuncts, and 26% more intraoperative adjuncts. The high ASG
category translated into a 55% increase in operating room supply costs and a
48% increase in hospital charges.
Conclusions: The ultimate utility of our study lies in its ability to
provide a framework for interpreting anatomic score into a clinically appli-
cable outcome of anticipated operative difficulty and expected outcomes,
defined by operative time, equipment needs, costs, and early outcomes. We
illustrated that a high anatomic score correlates with increased operating
times, length of hospital stay, blood loss, contrast use, and costs. We
demonstrated that with the use of the M2S software, one is able to quanti-
tatively describe the anatomic severity of aortic aneurysms. This score was an
important indicator of potential technical difficulties requiring more endo-
vascular implants and adjunctive maneuvers during EVAR.
Mesenteric/Celiac Duplex Ultrasound Interpretation Criteria Revisited
Ali F. AbuRahma, Patrick A. Stone,Mohit Srivastava, L. Scott Dean, Tammi
Keiffer, Stephen M. Hass, Albeir Y. Mousa, Robert C. Byrd Health Sciences
Center of West Virgiinia University, Charleston, WV
Background: Several published studies with limited sample size have
reported conflicting results of duplex (DUS) ultrasound utilizing different
threshold velocities in detecting significant stenosis (st.) of SMA or celiac
arteries (CA). This is the largest study to analyze various published diagnos-
tic criteria of SMA/CA st.
